Cytosorbents
CTSO
#10490
Rank
โ‚ฌ21.66 M
Marketcap
0,34ย โ‚ฌ
Share price
3.55%
Change (1 day)
-61.08%
Change (1 year)

Revenue for Cytosorbents (CTSO)

Revenue in 2026 (TTM): โ‚ฌ31.75 Million

According to Cytosorbents's latest financial reports the company's current revenue (TTM ) is โ‚ฌ32.58 Million. In 2025 the company made a revenue of โ‚ฌ31.55 Million a decrease over the revenue in the year 2024 that were of โ‚ฌ34.2 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cytosorbents from 2009 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ31.75 M0.66%
2025 โ‚ฌ31.55 M-7.76%
2024 โ‚ฌ34.2 M21.64%
2023 โ‚ฌ28.11 M2.74%
2022 โ‚ฌ27.37 M-22.72%
2021 โ‚ฌ35.41 M10.41%
2020 โ‚ฌ32.07 M57.83%
2019 โ‚ฌ20.32 M14.8%
2018 โ‚ฌ17.7 M58.73%
2017 โ‚ฌ11.15 M42.96%
2016 โ‚ฌ7.8 M110.32%
2015 โ‚ฌ3.7 M43.46%
2014 โ‚ฌ2.58 M334.5%
2013 โ‚ฌ0.59 M-250.38%
2012 -โ‚ฌ0.4 Million-1524.36%
2011 โ‚ฌ0.02 M
2010 N/A
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Boston Scientific
BSX
โ‚ฌ18.05 B 55,316.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
โ‚ฌ3.61 B 10,992.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO
โ‚ฌ0.29 B 795.21%๐Ÿ‡บ๐Ÿ‡ธ USA